zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
adakveo
novartis europharm limited - crizanlizumab - aneemia, sickle cell - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.
leqvio
novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipiidi modifitseerivad ained - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - kartsinoom, mitteväikerakk-kopsu - antineoplastilised ained - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
focetria
novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/california/7/2009 (h1n1)-derived strain used nymc x-181 - influenza, human; immunization; disease outbreaks - gripivaktsiinid - a (h1n1v) 2009 viirusega põhjustatud gripi profülaktika. focetria tuleks kasutada vastavalt euroopa liidu arendus.
maxidex silmatilgad, suspensioon
novartis baltics sia - deksametasoon - silmatilgad, suspensioon - 1mg 1ml 5ml 1tk
vigamox silmatilgad, lahus
novartis baltics sia - moksifloksatsiin - silmatilgad, lahus - 5mg 1ml 5ml 1tk
maxitrol silmatilgad, suspensioon
novartis baltics sia - deksametasoon+neomütsiin+polümüksiin b - silmatilgad, suspensioon - 1mg+3500rÜ+6000rÜ 1ml 5ml 1tk
lamisil tablett
novartis baltics sia - terbinafiin - tablett - 250mg 28tk; 250mg 14tk
tobradex silmasalv
novartis baltics sia - deksametasoon+tobramütsiin - silmasalv - 1mg+3mg 1g 3.5g 1tk